STOCK TITAN

MacroGenics: Jay Siegel proposes $131K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

MacroGenics, Inc. (MGNX) reports a proposed sale by Jay Siegel, a former director, of 34,916 common shares, with an aggregate market value of $130,935. The notice lists August 3, 2026 as the approximate sale date and Merrill Lynch as the broker.

Common shares proposed for sale 34,916 shares Approximate sale date: August 3, 2026
Aggregate market value $130,935 For the common shares listed for sale
Shares outstanding 63,563,123 shares Securities information section
Stock plan activity acquisition 20,166 shares August 3, 2026
Stock plan activity acquisition 3,750 shares May 18, 2026
Stock plan activity acquisition 6,500 shares May 20, 2025
Stock plan activity acquisition 4,500 shares May 20, 2024
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
stock plan activity technical
"Nature of Acquisition Transaction: Stock plan activity"
Number of Shares or Other Units Outstanding financial
"Number of Shares or Other Units Outstanding"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MGNX shares does former director Jay Siegel propose to sell?

Jay Siegel, identified as a former director of MacroGenics, reported a proposed sale of 34,916 common shares with an aggregate market value of $130,935; the approximate sale date is August 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading